自噬增强剂与活性氧清除剂对低剂量鱼藤酮诱导的轻度线粒体功能障碍小鼠行为与神经化学后果的改善作用
该研究在慢性低剂量鱼藤酮诱导的双相障碍样小鼠模型中,测试自噬增强剂(锂盐、海藻糖、白藜芦醇)和活性氧清除剂(白藜芦醇、N-乙酰半胱氨酸)单用或联用对行为及神经化学改变的影响。结果显示锂盐、海藻糖和N-乙酰半胱氨酸可逆转鱼藤酮诱导的躁狂样行为及线粒体复合体蛋白和自噬标志物LC3-II的偏差,但仅锂盐普遍改善抑郁样行为。提示自噬异常和活性氧升高可能参与躁狂样行为易感性,而抑郁样特征需不同的线粒体相关干预。
要点
- 锂盐、海藻糖和N-乙酰半胱氨酸可逆转鱼藤酮诱导的躁狂样行为及线粒体复合体蛋白和LC3-II偏差。
- 仅锂盐普遍改善八周鱼藤酮诱导的抑郁样行为,其他药物虽消除海马线粒体复合体蛋白升高但未改善抑郁样行为。
- 提示自噬异常和活性氧升高可能参与躁狂样行为易感性,而抑郁样特征需不同线粒体相关干预(如拮抗NMDAR)。
核心结论
- 在测试的自噬增强剂和活性氧清除剂中,锂盐总体上最有效对抗鱼藤酮诱导的改变。
- 海藻糖和N-乙酰半胱氨酸可能对减轻躁狂样行为有效。
- 自噬异常和/或活性氧升高可能不参与双相样行为抑郁相的易感性,改善抑郁样特征需要不同的线粒体相关干预。
研究设计与样本
- 采用慢性给予低剂量鱼藤酮(氧化磷酸化复合体I抑制剂)的小鼠双相障碍样模型。
- 鱼藤酮处理四周诱导躁狂样行为,八周诱导抑郁样行为,并伴随情绪相关神经化学改变。
- 测试自噬增强剂锂盐、海藻糖、白藜芦醇和活性氧清除剂白藜芦醇、N-乙酰半胱氨酸,以及锂盐+白藜芦醇或海藻糖+N-乙酰半胱氨酸的组合。
主要发现
- 锂盐、海藻糖和N-乙酰半胱氨酸逆转了鱼藤酮诱导的躁狂样行为以及线粒体复合体蛋白水平和自噬标志物LC3-II的偏差。
- 大多数测试药物消除了八周鱼藤酮诱导的海马所有线粒体复合体蛋白水平升高,但仅锂盐普遍改善了抑郁样行为。
- 提示轻度线粒体功能障碍伴随自噬受损和活性氧水平轻度升高可能与躁狂样行为易感性相关。
临床怎么用
- 锂盐在动物模型中显示出对鱼藤酮诱导的躁狂样和抑郁样行为均有改善作用。
- 海藻糖和N-乙酰半胱氨酸可能作为减轻躁狂样行为的潜在干预选项。
- 针对双相障碍抑郁相,可能需要不同于自噬增强或活性氧清除的线粒体相关干预策略(如拮抗NMDAR)。
局限性
- 研究为小鼠模型,结果向人类双相障碍的转化需谨慎。
- 抑郁样行为的改善机制尚未明确,NMDAR拮抗等推测需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bipolar-disorder's pathophysiology and the mechanism by which medications exert their beneficial effect is yet unknown, but others' and our data implicate patients' brain mitochondrial-dysfunction and its amendment by mood-stabilizers. We recently designed a novel mouse bipolar-disorder-like model using chronic administration of a low-dose of the oxidative-phosphorylation complex I inhibitor, rotenone. Four and eight weeks rotenone treatment induced manic- and depressive-like behavior, respectively, accompanied by mood-related neurochemical changes. Here we aimed to investigate whether each of the autophagy-enhancers lithium (a mood-stabilizer), trehalose and resveratrol and/or each of the reactive oxygen species (ROS)-scavengers, resveratrol and N-acetylcystein and/or the combinations lithium+resveratrol or trehalose+N-acetylcystein, can ameliorate behavioral and neurochemical consequences of neuronal mild mitochondrial-dysfunction. We observed that lithium, trehalose and N-acetylcystein reversed rotenone-induced manic-like behavior as well as deviations in protein levels of mitochondrial complexes and the autophagy marker LC3-II. This raises the possibility that mild mitochondrial-dysfunction accompanied by impaired autophagy and a very mild increase in ROS levels are related to predisposition to manic-like behavior. On the other hand, although, as expected, most of the drugs tested eliminated the eight weeks rotenone-induced increase in protein levels of all hippocampal mitochondrial complexes, only lithium ubiquitously ameliorated the depressive-like behaviors. We cautiously deduce that aberrant autophagy and/or elevated ROS levels are not involved in predisposition to the depressive phase of bipolar-like behavior. Rather, that amending the depressive-like characteristics requires different mitochondria-related interventions. The latter might be antagonizing N-methyl-D-aspartate receptors (NMDARs), thus protecting from disruption of mitochondrial calcium homeostasis and its detrimental consequences. In conclusion, our findings suggest that by-and-large, among the autophagy-enhancers and ROS-scavengers tested, lithium is the most effective in counteracting rotenone-induced changes. Trehalose and N-acetylcystein may also be effective in attenuating manic-like behavior.
引用
- Damri O, Natour S, Asslih S, et al. Does treatment with autophagy-enhancers and/or ROS-scavengers alleviate behavioral and neurochemical consequences of low-dose rotenone-induced mild mitochondrial dysfunction in mice? Mol Psychiatry. 2023. PMID: 36690794. doi:10.1038/s41380-023-01955-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。